Nonviral vectors might represent a safe alternative to adentransfection were obtained using neutral complexes. Under ovirus for gene therapy of lung disorders, in particular cyssuch conditions, luciferase activities corresponding to tic fibrosis (CF). Cationic lipids have been shown to correct about 10 3 RLU/10 s/mg of protein were reproducibly the CF defect both in vitro and in vivo, but more efficient obtained 2 days after transfection throughout the four lung vectors are needed to improve the low gene transfer lobes of newborn and adult rabbits. A nlslacZ reporter gene efficiency. Here, we show that the cationic polymer ExGen showed transfected cells around the lumen of large and 500, a linear polyethylenimine derivative, is more efficient small bronchi. No signs of acute toxicity (inflammation, than cationic lipids in transferring reporter genes to lung cellular infiltration etc) were detected by direct histopathoepithelial cells in vitro. In vivo ExGen 500 was able to logical analysis. Within 1 week after instillation, transgene mediate gene transfer into both newborn and adult rabbit expression decreased by two orders of magnitude. lungs with comparable efficiencies. The best levels of Keywords: gene therapy; cystic fibrosis; synthetic vectors; lung Among nonviral vectors two main classes of molecules can broadly be distinguished: cationic lipids such as Since the cloning of the cystic fibrosis (CF) gene in 1989, 1, 2 encouraging results towards the gene therapy of this disLipofectin, DOTAP or DOGS, and polymeric DNA-binding cations such as poly-l-lysine, protamine and polyease have been obtained. The observation that cystic fibrosis transmembrane conductance regulator (CFTR) ethylenimine (PEI) (Figure 1 ). The commercially available Lipofectin is a 1:1 mixture gene transfer corrects the CF bioelectric defect in many model systems stimulated the development of various of DOTMA and DOPE, a neutral lipid. Lipofectin has been shown to deliver reporter genes to the rodent airmolecular vectors, effective in transducing the most affected tissue, the lung. Adenoviruses were the first vectors ways via direct intratracheal injection 7, 8 or intravenous administration of lipid-DNA complexes.
9 Moreover, to be used for the gene therapy of CF, because of their ability to transfect nonreplicating cells and their tropism Lipofectin-DNA conjugates were able to mediate CFTR cDNA transfer to epithelial cells in vivo with reversal of for the respiratory airways. Phase I CF clinical trials showed that adenoviral vectors might be successful in the ion transport defect in transgenic CF mice. 10 DOTAP is a monocationic lipid that was able to transfer efficiently transferring the normal CFTR cDNA, although they may cause inflammation and immunological response. 3 New the lacZ reporter gene or CFTR cDNA into mice, without any inflammatory response. 11 The lipopolyamine DOGS viral vectors are now available; however, their ability to escape the immune response has still to be fully demon-(Transfectam) is characterized by a polycationic DNAcompacting headgroup, spermine. 12 We showed prestrated. 4 Recently, synthetic vectors have been suggested as an viously that DOGS/DOPE was able to transfer marker genes into the mouse upper airways after intratracheal alternative to replication defective viruses. Their major advantage is the lack of inflammatory reaction or instillation. 13 However, the low efficiency of transfection, despite the large amount of DNA used, together with the immunological response. Phase I clinical trials involving synthetic molecules (DC-Chol, DMRIE) were recently difficulty of reproducing results in independent experiments, led us to evaluate whether a new compound, performed in the USA and Europe. 5, 6 Preliminary results confirmed the safety of these compounds, although their ExGen 500, might be an alternative for in vitro and in vivo gene transfer to lung cells. ExGen 500 is a linear 22 kDa low gene transfer efficiency stressed the need for the development of more efficient molecules.
form of polyethylenimine, an organic polymer with a high cationic charge density potential. Similar branched molecules (PEI 800 kDa and PEI 25 kDa) were recently used to transfer marker genes to the newborn and adult gland cells are active in producing sticky mucus in CF patients and should be the target cells to be corrected by gene transfer. In contrast, ExGen 500 showed no cell transfection variability, being significantly more efficient than Lipofectin and DOTAP (P Ͻ 0.05) and DOGS (P Ͻ 0.025) even in submucosal cells. ExGen 500 complexes were characterized on the basis of their PEI nitrogen per DNA phosphate ratio (N/P) and expressed as ExGen 500 equivalents. Several ratios were tested (9:1, 5:1, 1:1). Assuming linear PEI-DNA complexes to have protonation profiles similar to that of branched PEI, 14 neutral complexes should be obtained for a N:P ratio of 5. Similar transfection values were obtained both with neutral (five equivalents) and positively charged complexes (nine equivalents), although signs of acute toxicity (cell detachment and death) were observed only when positively charged complexes were used (data not shown). In contrast, low transfection efficiency was obtained at negative ratios (10 5 RLU/10 s/mg of protein). Figure 2 shows that ExGen 500, at a neutral charge ratio, was more efficient than cationic lipids in transfecting epithelial cells in vitro, with values close to 10 9 RLU/10 s/mg of protein.
ExGen 500's high transfection efficiency might be explained by the 'proton sponge' effect which leads to osmotic swelling of endosomes containing the complexes. 20 However, the 'proton sponge' behaviour is not the only characteristic which makes PEI attractive for gene therapy purposes. Another major property of PEI is the possibility of reaching high efficiency of transfection by using complexes with a charge ratio close to neutrality. This might be advantageous for in vivo applications. Indeed, cationic lipid-DNA complexes bearing a strong positive charge do not mediate efficiently the gene transfer in vivo, since interaction with circulating serum proteins or with the anionic tissue matrix hinders their bio-availability. 21 Furthermore, positively charged complexes also activate complement and complement-dependent phagocytosis by macrophages in the reticuloendo- newborn rabbits' trachea. Forty-eight hours after injection, the animals were killed and trachea and lung lobes were analysed for luciferase activity or ␤-galactosidase (CFPEo − , CFNPEo − and 6CFSMEo − ) and normal trachea cells (9HTEo − ). 16, 17 Transfections with Lipofectin, DOTAP expression by X-gal staining. When 100, 300 and 700 g DNA were complexed to and DOGS were performed using positively charged complexes since it has been shown that in vitro transfec-DOGS to form positively charged complexes (6:1 charge ratio), none of the 30 animals was positive for luciferase tion with cationic lipids is best when the nucleolipid particles bear strong net positive charge.
12, [18] [19] activity or ␤-galactosidase expression. On the other hand, when DOGS, in association with DOPE, was used at neu- Figure 2 shows that DOGS is more efficient than Lipofectin and DOTAP in nasal polyp and tracheal cells, tral conditions (1:1 DOGS-DOPE:DNA charge ratio) and complexed to 1 mg DNA, some animals (four out of 60) reaching values ranging from 2 × 10 7 to 10 8 RLU/10 s/mg of protein. DOGS's efficiency may be due to its least basic were positive for ␤-galactosidase staining. Transfection efficiency was low (Ͻ0.01%) and restricted to the injecsecondary amine (pK 4 = 5.4) which is able to buffer acidic endosomes and protect DNA from degradation. 18 On the tion site (data not shown), as previously described in mice. 13 other hand, for reasons that have still to be understood, DOGS is less efficient on submucosal gland cells, reachIn sharp contrast to DOGS, ExGen 500 was able to deliver DNA efficiently and reproducibly. Twenty-four ing values of 2 × 10 7 RLU/10 s/mg of protein. This result should be taken into consideration when in vivo experinewborn rabbits were analysed for ␤-galactosidase expression following instillation of ExGen 500-DNA ments are planned, since cell transfection variability might compromise their outcome. In fact, submucosal complexes at neutral, negative and positive surface 
the transfection mixture was added to the cells. Transfection was set up in 10% FCS medium. Luciferase gene expression was monitored 24 h later by using the Luciferase Assay System (Promega) and photon counting. Each transfection experiment was performed in triplicate and expressed as the mean of relative light units per 10 s per mg of cell protein (measured by Bradford method) ± s.d. A statistical analysis of the data was performed using an analysis of variance (ANOVA) test (see text for details).
charge. Forty-eight hours after gene transfer, rabbit lungs protection from degradation before reaching the distal lung cells. were removed en bloc and stained for lacZ activity. In all 24 animals, X-gal staining produced a predominantly On the other hand, high levels of toxicity became evident when positively charged complexes (N/P = 9) were bilateral perihilar pattern of reporter gene expression (Figure 3a) . No X-gal staining was observed in control used. Lung sections from rabbits treated with high amounts of ExGen 500 showed the presence of monoanimals.
In order to evaluate the histologic distribution of nuclear and red blood cell infiltration (Figure 3f ), which was not visible at lower N/P ratios. reporter gene expression, 10-15 frozen sections were cut from each lung lobe of each injected animal. When neuIn order to evaluate the dose dependency of in vivo transfection, 100, 300 and 700 g DNA were mixed with tral complexes (N/P = 5) were injected, ␤-galactosidase expressing cells were detected in the trachea (Figure 3b ) ExGen 500 at a neutral (N/P = 5) ratio in 300 l 5% sucrose solution and injected directly into the newborn as well as around the lumen of large and small bronchi (Figure 3d and e) . Blue cells were found in upper and rabbits' tracheae. Forty-eight hours later, rabbits were killed; trachea and lung lobes were excised and transfeclower lung lobes and we estimated that 1-2% of the cells in each section were positive to X-gal staining. By using tion efficiency was quantified by a luciferase assay. No activity was detected when 100 g DNA were used. Figthis condition, in fact, increased particles' half-life and a consequently higher probability of reaching distant cells ure 4 shows that no significant difference (P Ͻ 0.2) in luciferase activity was detected when 300 or 700 g DNA was expected.
When negatively charged complexes (N/P = 1) were were injected (average 10 3 RLU/10 s/mg of protein). Similar experiments performed by using the pCMVinjected, transfection efficiency was restricted to tracheal cells and no ␤-galactosidase expressing cells were found nlslacZ construct confirmed de visu that no difference in the number of transfected cells could be observed followin lung sections. This might be due to a reduced DNA ing the injection of 300 g or 700 g DNA (data not some-DNA complexes in transfecting mouse airway epishown). These results might be due to the clumping of thelial tissue. 23 From the data shown in Figure 4 , it was complexes which was observed at concentration Ͼ1 evident that ExGen 500 was essential to mediate gene g/l. This phenomenon in turn would result in a transfer into rabbit lungs: naked DNA was unable to decreased diffusibility of complexes through the extradeliver DNA to airways cells (Ͻ10 RLU/10 s/mg of cellular space as well as in a reduced probability of protein). However naked DNA was able to transfect being endocytosed. tracheal cells to some extent (average 4 × 10 2 RLU/10 To ascertain further whether in vivo transfection of s/mg of protein) and X-gal staining was observed around lung epithelial cells was mediated by ExGen 500, control the site of injection (Figure 3c ). animals were injected with naked DNA. Indeed, it was Based on these observations, to demonstrate that adult shown recently that naked DNA was as effective as lipoanimals could be transfected as well as newborns, we injected 300 or 700 g DNA at 1 g/l concentration into 30-day-old rabbits (1.5 kg weight). As shown in Figure 5 , human primates and in a phase I clinical trial in order 
